In vitro modulation of the human gastrointestinal microbial community by plant-derived polysaccharide-rich dietary supplements

International Journal of Food Microbiology

Volumn 139, Issue 3, 2010, Pages 168-176

  Marzorati, M ^a   Verhelst, A ^b   Luta, G ^c   Sinnott, R ^c   Verstraete, W ^a   de Wiele, T V ^a   Possemiers, S ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b ProDigest ^*  (Belgium)

^c Mannatech Inc   (United States)

Author keywords

Ambrotose; Bifidobacteria; Colonic fermentation; Gastrointestinal Resource Management; Glyconutrients; Prebiotic

Indexed keywords

POLYSACCHARIDE;

ADULT; ARTICLE; BACTERIAL METABOLISM; BACTERIUM EXAMINATION; BACTEROIDES; BIFIDOBACTERIUM; BODY WEIGHT; COLON FLORA; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DIET SUPPLEMENTATION; FOOD COMPOSITION; HUMAN; IN VITRO STUDY; INTESTINE FLORA; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; MICROBIAL MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION DENSITY; PREVOTELLA; QUANTITATIVE ANALYSIS; SPECIES COMPOSITION;

BACTEROIDES; BIFIDOBACTERIUM; DIETARY SUPPLEMENTS; FATTY ACIDS, VOLATILE; FERMENTATION; GALACTANS; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLACEAE; PLANT GUMS; PLANTS; POLYSACCHARIDES; PREBIOTICS;

BACTEROIDES; BACTEROIDETES; PREVOTELLA;

EID: 77952237175     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.02.030     Document Type: Article

References (54)

1. Baumgart D.C., Sandborn W.J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007, 369:1641-1657.
2. Boon N., Top E.M., Verstraete W., Siciliano S.D. Bioaugmentation as a tool to protect the structure and function of an activated sludge microbial community against a 3-chloroaniline shock load. Applied and Environmental Microbiology 2003, 69:1511-1520.
3. Crociani F., Alessandrini A., Mucci M.M., Biavati B. Degradation of complex carbohydrates by Bifidobacterium spp. International Journal of Food Microbiology 1994, 24:199-210.
4. Cummings J.H., Macfarlane G.T. The control and consequences of bacterial fermentation in the human colon. Journal of Applied Bacteriology 1991, 70:443-459.
5. De Boever P., Deplancke B., Verstraete W. Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. Journal of Nutrition 2000, 130:2599-2606.
6. Decroos K., Eeckhaut E., Possemiers S., Verstraete W. Administration of equol-producing bacteria alters the equol production status in the simulator of the gastrointestinal microbial ecosystem (SHIME). Journal of Nutrition 2006, 136:946-952.
7. Degnan B.A., Macfarlane G.T. Arabinogalactan utilization in continuous cultures of Bifidobacterium longum: effect of co-culture with Bacteroides thetaiotaomicron. Anaerobe 1995, 1:103-112.
8. Duncan S.H., Louis P., Flint H.J. Lactate-utilizing bacteria, isolated from human feces that produce butyrate as a major fermentation product. Applied and Environmental Microbiology 2004, 70:5810-5817.
9. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
10. Eshun K., He Q. Aloe vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries - a review. Critical Reviews in Food Science and Nutrition 2004, 44:91-96.
11. Gibson G.R., Probert H.M., Loo J.V., Rastall R.A., Roberfroid M.B. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutrition Research Reviews 2004, 17:259-275.
12. Grootaert C., Van den Abbeele P., Marzorati M., Broekaert W.F., Courtin C.M., Delcour J.A., Verstraete W., Van de Wiele T. Comparison of prebiotic effects of arabinoxylan oligosaccharides and inulin in a simulator of the human intestinal microbial ecosystem. FEMS Microbiology Ecology 2009, 69:231-242.
13. Guo X., Xia X., Tang R., Zhou J., Zhao H., Wang K. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Letters in Applied Microbiology 2008, 47:367-373.
14. Hartemink R., Kok B.J., Weenk G.H., Rombouts F.M. Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria. Journal of Microbiological Methods 1996, 27:33-43.
15. Hartemink R., Domenech V.R., Rombouts F.M. LAMVAB - a new selective medium for the isolation of lactobacilli from faeces. Journal of Microbiological Methods 1997, 29:77-84.
16. Heilig H.G., Zoetendal H.J., Vaughan E.G., Marteau E.E., Akkermans P., de Vos W.M. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Applied and Environmental Microbiology 2002, 68:114-123.
17. Inoue T., Murano M., Kuramoto T., Ishida K., Kawakami K., Abe Y., Morita E., Murano N., Toshina K., Nishikawa T., Maemura K., Shimamoto C., Hirata I., Katsu K., Higuchi K. Increased proliferation of middle to distal colonic cells during colorectal carcinogenesis in experimental murine ulcerative colitis. Oncology Reports 2007, 18:1457-1462.
18. Kelly G. Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Alternative Medicine Review 1999, 4:96-103.
19. Khailova L., Dvorak K., Arganbright K.M., Halpern M.D., Kinouchi T., Yajima M., Dvorak B. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. American Journal of Physiology - Gastrointestinal and Liver Physiology 2009, Electronic publication (PMID: 19713473).
20. Kim L.S., Waters R.F., Burkholder P.M. Immunological activity of larch arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-controlled trial. Alternative Medicine Review 2002, 7:138-149.
21. Koetzner L., Grover G., Boulet J., Jacoby H.I. Plant-derived polysaccharide supplements inhibit dextran sulfate sodium-induced colitis in the rat. Digestive Diseases and Sciences 2009, (Electronic publication ahead of print).
22. Langmead L., Feakins R.M., Goldthorpe S., Holt H., Tsironi E., De Silva A., Jewell D.P., Rampton D.S. Randomized, double-blind, placebo-controlled trial of oral Aloe vera gel for active ulcerative colitis. Alimentary Pharmacology & Therapeutics 2004, 19:739-747.
23. Leser T.D., Mølbak L. Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. Environmental Microbiology 2009, 11:2194-2206.
24. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences USA 2005, 102:11070-11075.
25. Lorenz M.O. Methods of measuring concentration of wealth. Journal of the American Statistical Association 1905, 9:209-219.
26. Luta G., Duncan C., Sinnott R. Chemical characterization of polysaccharide-rich ingredients from Aloe vera, Larix laricina and Larix occidentalis, and Undaria pinatifida. Scripps Center for Integrative Medicine's 6th Annual Natural Supplements Conference, San Diego, California. January 2009 2009.
27. Macfarlane G.T., Gibson G.R., Cummings J.H. Comparison of fermentation reactions in different regions of the human colon. Journal of Applied Bacteriology 1992, 72:57-64.
28. Macfarlane G.T., Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scandinavian Journal of Gastroenterology 1997, 32:3-9.
29. Macfarlane S., Macfarlane G.T. Regulation of short-chain fatty acid production. Proceedings of the Nutrition Society 2003, 62:67-72.
30. Manning T.S., Gibson G.R. Microbial-gut interactions in health and disease: prebiotics. Best Practice & Research Clinical Gastroenterology 2004, 18:287-298.
31. Marzorati M., Wittebolle L., Boon N., Daffonchio D., Verstraete W. How to get more out of molecular fingerprints: practical tools for microbial ecology. Environmental Microbiology 2008, 10:1571-1581.
32. Marzorati M., Possemiers S., Verstraete W. The use of the SHIME-related technology platform to assess the efficacy of pre- and probiotics. Agro Food Industry Hi-Tech 2009, 20:S50-S53.
33. Ménard O., Butel M.J., Gaboriau-Routhiau V., Waligora-Dupriet A.J. Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Applied and Environmental Microbiology 2008, 74:660-666.
34. Newburg D.S. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. Journal of Animal Science 2009, 87(13 Suppl):26-34.
35. Ovreas L., Forney L., Daae F.L., Torsvik V. Distribution of bacterioplankton in meromictic Lake Saelenvannet, as determined by denaturing gradient gel electrophoresis of PCR amplified gene fragments coding for 16S rRNA. Applied and Environmental Microbiology 1997, 63:3367-3373.
36. Patankar M.S., Oehninger S., Barnett T., Williams R.L., Clark G.F. A revised structure for fucoid may explain some of its biological activities. The Journal of Biological Chemistry 1993, 268:21770-21776.
37. Pogribna M., Freeman J.P., Paine D., Boudreau M.D. Effect of Aloe vera whole leaf extract on short chain fatty acids production by Bacteroides fragilis, Bifidobacterium infantis and Eubacterium limosum. Letters in Applied Microbiology 2008, 46:575-580.
38. Possemiers S., Verthé K., Uyttendaele S., Verstraete W. PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiology Ecology 2004, 49:495-507.
39. Possemiers S., Bolca S., Grootaert C., Heyerick A., Decroos K., Dhooge W., De Keukeleire D., Rabot S., Verstraete W., Van de Wiele T. The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. Journal of Nutrition 2006, 136:1862-1867.
40. Possemiers S., Grootaert C., Vermeiren J., Gross G., Marzorati M., Verstraete W., Van de Wiele T. The intestinal environment in health and disease - recent insights on the potential of intestinal bacteria to influence human health. Current Pharmaceutical Design 2009, 15:2051-2065.
41. Robinson R.R., Feirtag J., Slavin J.L. Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects. Journal of the American College of Nutrition 2001, 20:279-285.
42. Rinttilä T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. Journal of Applied Microbiology 2004, 97:1166-1177.
43. Sanchez J.I., Marzorati M., Grootaert C., Baran M., Van Craeyveld V., Courtin C.M., Broekaert W.F., Delcour J.A., Verstraete W., Van de Wiele T. Arabinoxylan-oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the simulator of human intestinal microbial ecosystem. Microbial Biotechnology 2009, 2:101-113.
44. Satokari R.M., Vaughan E.E., Akkermans A.D.L., Saarela M., de Vos W.M. Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Applied and Environmental Microbiology 2001, 67:504-513.
45. Smith E.A., Macfarlane G.T. Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microbial Ecology 1997, 33:180-188.
46. Topping D.L., Clifton P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiological Reviews 2001, 81:1031-1064.
47. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
48. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature 2007, 449:804-810.
49. Van de Wiele T., Boon N., Possemiers S., Jacobs H., Verstraete W. Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiology Ecology 2004, 51:143-153.
50. Van de Wiele T., Boon N., Possemiers S., Jacobs H., Verstraete W. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. Journal of Applied Microbiology 2007, 102:452-460.
51. Wittebolle L., Boon N., Vanparys B., Heylen K., De Vos P., Verstraete W. Failure of the ammonia oxidation process in two pharmaceutical wastewater treatment plants is linked to shifts in the bacterial communities. Journal of Applied Microbiology 2005, 99:997-1006.
52. Wittebolle L., Vervaeren H., Verstraete W., Boon N. Quantifying community dynamics of nitrifiers in functionally stable reactors. Applied and Environmental Microbiology 2008, 74:286-293.
53. Wittebolle L., Verstraete W., Boon N. The inoculum effect on the ammonia-oxidizing bacterial communities in parallel sequential batch reactors. Water Research 2009, 43:4149-4158.
54. Zoetendal E.G., Akkermans A.D.L., de Vos W.M. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Applied and Environmental Microbiology 1998, 64:3854-3859.